IWA
TEVA icon

Intercontinental Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Intercontinental Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,694
Closed -$216K – 142
2016
Q3 		$216K Sell
4,694
-41
-0.9% -$2.14K 0.15% 113
2016
Q2 		$238K Buy
+4,735
New +$252K 0.18% 110

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Intercontinental Wealth Advisors's TEVA Position: Q4 2016 in Review

Intercontinental Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 4,694 shares — an estimated $216K sold.

Intercontinental Wealth Advisors first reported a position in TEVA in Q2 2016 and held it in 2 quarters. The position peaked at $238K in Q2 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Intercontinental Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 4,694 Teva Pharmaceuticals shares in Q4 2016, an estimated $216K.
  • Intercontinental Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Intercontinental Wealth Advisors's Teva Pharmaceuticals position peaked at $238K in Q2 2016.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Intercontinental Wealth Advisors's 13F filing for Q4 2016, filed 9 Mar 2018.